Gloria Vachino is a faculty appointed Instructor in Biochemistry at the Boston University School of Medicine. She holds a MS in Immunology from Tufts University’s Sackler School of Graduate Biomedical Sciences and has a joint honors BS in Biology and Psychology from the University College of Wales in Great Britain. In the BLCS (Biomedical Laboratory and Clinical Science) program, she currently teaches Biotechnology I and II, and Math for the Laboratory and has taught Introduction to Biomedical Lab Science, and Drug Discovery and Biotechnology. She has also conducted workshops for high school and community college educators at the Museum of Science Annual Symposium on Biotechnology Education, and taught lab and academic courses for 5 years in the Cambridge Biomedical Careers Program through Just A Start Corp. / Bunker Hill Community College.
- Tufts University, MS
- University of Wales, BS
- Published on 4/15/1997
Lichtman AH, Ding H, Henault L, Vachino G, Camphausen R, Cumming D, Luscinskas FW. CD45RA-RO+ (memory) but not CD45RA+RO- (naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. J Immunol. 1997 Apr 15; 158(8):3640-50. PMID: 9103426.
- Published on 11/1/1996
Goetz DJ, Ding H, Atkinson WJ, Vachino G, Camphausen RT, Cumming DA, Luscinskas FW. A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol. 1996 Nov; 149(5):1661-73. PMID: 8909255.
- Published on 9/15/1995
Vachino G, Chang XJ, Veldman GM, Kumar R, Sako D, Fouser LA, Berndt MC, Cumming DA. P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem. 1995 Sep 15; 270(37):21966-74. PMID: 7545173.
- Published on 12/17/1993
Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993 Dec 17; 75(6):1179-86. PMID: 7505206.
- Published on 11/1/1993
Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993 Nov 1; 178(5):1629-36. PMID: 7693853.
- Published on 11/1/1992
Atkins MB, Vachino G, Tilg HJ, Karp DD, Robert NJ, Kappler K, Mier JW. Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. J Clin Oncol. 1992 Nov; 10(11):1802-9. PMID: 1403061.
- Published on 11/15/1991
Vachino G, Gelfand JA, Atkins MB, Tamerius JD, Demchak P, Mier JW. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes. Blood. 1991 Nov 15; 78(10):2505-13. PMID: 1824247.
- Published on 11/15/1990
Mier JW, Vachino G, Klempner MS, Aronson FR, Noring R, Smith S, Brandon EP, Laird W, Atkins MB. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15; 76(10):1933-40. PMID: 2242421.
- Published on 1/1/1990
Yamada Y, Kimball K, Okusawa S, Vachino G, Margolis N, Sohn JW, Li JJ, Wakabayashi G, McAdam K, Burke JF, et al. Cytokines, acute phase proteins, and tissue injury. C-reactive protein opsonizes dead cells for debridement and stimulates cytokine production. Ann N Y Acad Sci. 1990; 587:351-61. PMID: 2193581.
- Published on 12/1/1988
Vachino G, Heck LW, Gelfand JA, Kaplan MM, Burke JF, Berninger RW, McAdam KP. Inhibition of human neutrophil and Pseudomonas elastases by the amyloid P-component: a constituent of elastic fibers and amyloid deposits. J Leukoc Biol. 1988 Dec; 44(6):529-34. PMID: 3264008.
View 3 more publications: View full profile at BUMC